for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Autobio Diagnostics Co Ltd

603658.SS

Latest Trade

110.18CNY

Change

-0.01(-0.01%)

Volume

1,088,328

Today's Range

109.12

 - 

112.00

52 Week Range

49.25

 - 

113.04

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
110.19
Open
110.28
Volume
1,088,328
3M AVG Volume
31.18
Today's High
112.00
Today's Low
109.12
52 Week High
113.04
52 Week Low
49.25
Shares Out (MIL)
420.00
Market Cap (MIL)
46,279.80
Forward P/E
62.55
Dividend (Yield %)
0.73

Latest Developments

More

Z&F Int'l Trading Plans To Unload Up To 3% Stake In Autobio Diagnostics Within Six Months

Autobio Diagnostics' Controlling Shareholder To Unload Up To 3% Stake In The Company

Autobio Diagnostics' 9-Month Net Profit Up 30.9% Y/Y

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Autobio Diagnostics Co Ltd

Autobio Diagnostics Co., Ltd. is a China-based company and mainly engaged in development, manufacture and sales of diagnostics products. The Company's main products include gnostic products, microbiology detection products, and related devices. The immunodiagnostic products include microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The microbiology detection products include training detection reagents, susceptibility detection reagents and rapid detection reagents. The device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. The Company distributes its products in domestic markets.

Industry

Biotechnology & Drugs

Contact Info

No.87 Jingbei Yi Rd.

National Eco, Zhengzhou, Henan 450016

+86.371.86506868

http://www.autobio.com.cn/

Executive Leadership

Yongjun Miao

Chairman of the Board

Yaxun Zhang

Vice Chairman of the Board

Chaojie Feng

Chief Financial Officer, Deputy General Manager, Director

Xuewei Wu

General Manager, Director

Ruikuan Fang

Deputy General Manager, Secretary of the Board

Key Stats

1.45 mean rating - 11 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2016

1.0K

2017

1.4K

2018

1.9K

2019(E)

2.6K
EPS (CNY)

2016

0.890

2017

1.060

2018

1.340

2019(E)

1.761
Price To Earnings (TTM)
67.12
Price To Sales (TTM)
18.79
Price To Book (MRQ)
19.94
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
35.61
LT Debt To Equity (MRQ)
21.27
Return on Investment (TTM)
29.47
Return on Equity (TTM)
22.43

Latest News

Latest News

BRIEF-Autobio Diagnostics sees FY 2017 net profit up 20 pct to 35 pct

* Says it sees net profit for FY 2017 to increase by 20 percent to 35 percent

BRIEF-Autobio Diagnostics unit obtains high-tech enterprise recognition and to enjoy tax preference

* Says co's Beijing-based biotechnology unit was recognized as high-tech enterprise, and to enjoy a tax preference of 15 percent for three years from 2017 to 2019

BRIEF-Autobio Diagnostics Expects Net Profit To Rise 20-35 Percent Y/Y In 2017

* SAYS IT EXPECTS NET PROFIT TO RISE 20-35 PERCENT Y/Y IN 2017 VERSUS 349.76 MILLION YUAN ($55.16 million) YEAR AGO Source text in Chinese: http://bit.ly/2nnOiln Further company coverage: ($1 = 6.3410 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

BRIEF-Autobio Diagnostics obtains high-tech enterprise recognition

* Says it will enjoy tax preference of 15 percent for three years from Aug. 29

BRIEF-Autobio Diagnostics obtains high-tech enterprise recognition and to enjoy tax preference

* Says the company was recognized as high-tech enterprise, and to enjoy a tax preference of 15 percent for three years from 2017 to 2019

BRIEF-Autobio Diagnostics to invest A$2 mln in Australia's LBT Innovations

* Says it plans to invest A$2 million ($1.53 million) in Australia's LBT Innovations Ltd

BRIEF-Autobio Diagnostics to invest 3.6 mln yuan to set up medical technology company

* Says it will invest 3.6 million yuan to set up a Hebei-based medical technology company with partners

BRIEF-Autobio Diagnostics acquires 75 pct stake in Beijing-based bio-tech firm

* Says co completes acquisition of 75 percent stake in Beijing-based bio-tech firm

BRIEF-Autobio Diagnostics to invest in 75 pct stake in bio-tech firm Bio-top

* Says it plans to invest up to 202.5 million yuan ($29.32 million) for 75 percent stake in Beijing-based bio-tech firm Bio-top

BRIEF-Autobio Diagnostics to pay A shares annual div for FY 2016 on April 13

* Says it will pay cash dividend of 0.65 yuan(before tax)/share for 2016 to shareholders of record on April 12

BRIEF-Autobio Diagnostics to pay cash 6.5 yuan per 10 shares as 2016 div payment

* Says it plans to pay cash 6.5 yuan per 10 shares as 2016 div payment

BRIEF-Autobio Diagnostics sees FY2016 net profit to up by 20 pct to 35 pct

* Sees net profit for FY2016 to increase by 20 percent to 35 percent, or to be 334 million yuan to 375 million yuan, compared to net profit of FY2015 (278 million yuan)

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up